Domestic brokerage firm Nuvama analysts forecast a modest sequential slowdown but a healthy ~17 per cent year-on-year (Y-o-Y) Ebitda growth, led by hospitals and diagnostics.
The CGHS rate revision could lift hospital chains' revenues and margins, say analysts. Here are the listed stocks set to benefit most from the policy update
Coffee with BS: Meet Prathap C Reddy, founder-chairman, Apollo Hospitals
Multiple triggers could help Apollo Hospitals to reverse underperformance
Stocks to Watch today, September 24, 2025: IHCL, Swiggy, Akzo Nobel and other stocks will be in focus today; here's why
Apollo Hospitals to expand genomics institutes to Tier-2 cities including Guwahati, Bhubaneswar and Indore, aiming to cut test costs and boost access beyond metro regions
Apollo Hospitals to acquire IFC's 30.58% stake in AHLL for Rs 1,254 crore, taking ownership to 99.42%, and invest Rs 573 crore in a next-gen proton therapy centre in Gurugram
Promoter group raises Rs 1,489 cr to reduce debt and holdings; doesn't plan further stake reduction
Stocks to Watch today, August 22, 2025: IDBI Bank, Karnataka Bank, Wipro, Hindalco are among the few stocks that will be on investors' radar; here's why
Apollo Hospitals MD Suneeta Reddy plans to sell her 1.25% stake worth Rs 1,395 crore through block deals, reducing her holding to 2.11%
Here is the complete list of stocks that will remain in focus today as they trade ex-dividend on August 19, along with their key details
For Q1FY26, Apollo Hospitals' consolidated revenue grew 15 per cent year-on-year (Y-o-Y) to ₹5,842 crore, driven by all three business segments.
Apollo Hospitals posted a 42% rise in Q1 net profit to Rs 432.8 crore and announced a Rs 7,600 crore investment plan to add over 4,300 beds in five years
Stocks to buy: Analyst at Religare recommends Sun Pharma, Apollo Hospitals; Check target price, stop loss here
Apollo and Siemens Healthineers will collaborate on AI and imaging research for early detection, diagnosis, and monitoring of liver diseases including MASLD in India
With significant untapped market opportunities and a shortage of healthcare infrastructure in India, leading Indian companies have immense potential for expansion.
New entity combining Apollo 24/7, HealthCo, and Keimed aims for Rs 25,000 crore revenue by FY27 with 7% EBITDA margin; IPO planned in 18-21 months
The hospital operator will retain a 15 per cent stake in the entity, which it is yet to be named, and will also have its nominee on the board of the new company
Apollo anticipates a 140 basis points hit to operating profit margins in FY26 due to new hospitals
Apollo Hospitals Enterprise shares rose on the back of strong performance for the quarter ended March 31, 2025 (Q4FY25), with a year-on-year (Y-o-Y) growth across key financial indicators.